File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Prevention of age-related macular degeneration

TitlePrevention of age-related macular degeneration
Authors
KeywordsAge-related macular degeneration
AMD
AREDS
Beta-carotene
Neovascular AMD
Prevention
Sunlight filtration
Vitamin E
Yellow IOL
Issue Date2011
PublisherSpringer Verlag Dordrecht. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0165-5701
Citation
International Ophthalmology, 2011, v. 31 n. 1, p. 73-82 How to Cite?
AbstractAge-related macular degeneration (AMD) is one of the leading causes of blindness in the developed world. Although effective treatment modalities such as anti-VEGF treatment have been developed for neovascular AMD, there is still no effective treatment for geographical atrophy, and therefore the most cost-effective management of AMD is to start with prevention. This review looks at current evidence on preventive measures targeted at AMD. Modalities reviewed include (1) nutritional supplements such as the Age-Related Eye Disease Study (AREDS) formula, lutein and zeaxanthin, omega-3 fatty acid, and berry extracts, (2) lifestyle modifications, including smoking and body-mass-index, and (3) filtering sunlight, i.e. sunglasses and blue-blocking intraocular lenses. In summary, the only proven effective preventive measures are stopping smoking and the AREDS formula. © 2010 The Author(s).
DescriptionReview
Persistent Identifierhttp://hdl.handle.net/10722/133799
ISSN
2015 Impact Factor: 0.959
2015 SCImago Journal Rankings: 0.526
PubMed Central ID
References

 

DC FieldValueLanguage
dc.contributor.authorWong, IYHen_HK
dc.contributor.authorKoo, SCYen_HK
dc.contributor.authorChan, CWNen_HK
dc.date.accessioned2011-05-31T06:29:55Z-
dc.date.available2011-05-31T06:29:55Z-
dc.date.issued2011en_HK
dc.identifier.citationInternational Ophthalmology, 2011, v. 31 n. 1, p. 73-82en_HK
dc.identifier.issn0165-5701en_HK
dc.identifier.urihttp://hdl.handle.net/10722/133799-
dc.descriptionReview-
dc.description.abstractAge-related macular degeneration (AMD) is one of the leading causes of blindness in the developed world. Although effective treatment modalities such as anti-VEGF treatment have been developed for neovascular AMD, there is still no effective treatment for geographical atrophy, and therefore the most cost-effective management of AMD is to start with prevention. This review looks at current evidence on preventive measures targeted at AMD. Modalities reviewed include (1) nutritional supplements such as the Age-Related Eye Disease Study (AREDS) formula, lutein and zeaxanthin, omega-3 fatty acid, and berry extracts, (2) lifestyle modifications, including smoking and body-mass-index, and (3) filtering sunlight, i.e. sunglasses and blue-blocking intraocular lenses. In summary, the only proven effective preventive measures are stopping smoking and the AREDS formula. © 2010 The Author(s).en_HK
dc.languageengen_US
dc.publisherSpringer Verlag Dordrecht. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0165-5701en_HK
dc.relation.ispartofInternational Ophthalmologyen_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.rightsThe original publication is available at www.springerlink.comen_US
dc.rightsThe Author(s)-
dc.subjectAge-related macular degenerationen_HK
dc.subjectAMDen_HK
dc.subjectAREDSen_HK
dc.subjectBeta-caroteneen_HK
dc.subjectNeovascular AMDen_HK
dc.subjectPreventionen_HK
dc.subjectSunlight filtrationen_HK
dc.subjectVitamin Een_HK
dc.subjectYellow IOLen_HK
dc.subject.meshDietary Supplements-
dc.subject.meshFatty Acids, Omega-3 - administration and dosage-
dc.subject.meshLenses, Intraocular-
dc.subject.meshLutein - therapeutic use-
dc.subject.meshMacular Degeneration - etiology - prevention and control-
dc.titlePrevention of age-related macular degenerationen_HK
dc.typeArticleen_HK
dc.identifier.emailWong, IYH: wongyhi@hku.hken_HK
dc.identifier.authorityWong, IYH=rp01467en_HK
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1007/s10792-010-9397-5en_HK
dc.identifier.pmid20862519-
dc.identifier.pmcidPMC3021198-
dc.identifier.scopuseid_2-s2.0-78751646013en_HK
dc.identifier.hkuros186969-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-78751646013&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume31en_HK
dc.identifier.issue1en_HK
dc.identifier.spage73en_HK
dc.identifier.epage82en_HK
dc.identifier.eissn1573-2630en_US
dc.publisher.placeNetherlandsen_HK
dc.description.otherSpringer Open Choice, 31 May 2011en_US
dc.identifier.scopusauthoridWong, IYH=36490557200en_HK
dc.identifier.scopusauthoridKoo, SCY=36489848200en_HK
dc.identifier.scopusauthoridChan, CWN=8266387300en_HK
dc.identifier.citeulike7911531-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats